The role of HOXA1 in cancer and targeted therapy.
Saved in:
| Title: | The role of HOXA1 in cancer and targeted therapy. |
|---|---|
| Authors: | Dong J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn., Gong H; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China., Li J; China-US(Henan) Hormel Cancer Institute, No.127, Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China., Ma X; China-US(Henan) Hormel Cancer Institute, No.127, Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China., Tayyab B; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China., Xu X; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2025 Aug 04; Vol. 42 (9), pp. 405. Date of Electronic Publication: 2025 Aug 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40760270 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The role of HOXA1 in cancer and targeted therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dong+J%22">Dong J</searchLink>; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Gong+H%22">Gong H</searchLink>; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; China-US(Henan) Hormel Cancer Institute, No.127, Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China.<br /><searchLink fieldCode="AU" term="%22Ma+X%22">Ma X</searchLink>; China-US(Henan) Hormel Cancer Institute, No.127, Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China.<br /><searchLink fieldCode="AU" term="%22Tayyab+B%22">Tayyab B</searchLink>; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China.<br /><searchLink fieldCode="AU" term="%22Xu+X%22">Xu X</searchLink>; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229435512%22">Medical oncology (Northwood, London, England)</searchLink> [Med Oncol] 2025 Aug 04; Vol. 42 (9), pp. 405. <i>Date of Electronic Publication: </i>2025 Aug 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9435512 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-131X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213570560%22">13570560 </searchLink><i>NLM ISO Abbreviation: </i>Med Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40760270 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12032-025-02980-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 405 Titles: – TitleFull: The role of HOXA1 in cancer and targeted therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dong J – PersonEntity: Name: NameFull: Gong H – PersonEntity: Name: NameFull: Li J – PersonEntity: Name: NameFull: Ma X – PersonEntity: Name: NameFull: Tayyab B – PersonEntity: Name: NameFull: Xu X IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 08 Text: 2025 Aug 04 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1559-131X Numbering: – Type: volume Value: 42 – Type: issue Value: 9 Titles: – TitleFull: Medical oncology (Northwood, London, England) Type: main |
| ResultId | 1 |
